Home | Welcome to Contract Pharma   
Last Updated Thursday, August 28 2014
Print RSS Feed

Breaking News

Kristin Brooks
January 31, 2014
Consolidation creates Actavis Pharma and Actavis Global R&D  Read More »
Kristin Brooks
January 31, 2014
Revenues down 2% in the quarter  Read More »
Kristin Brooks
January 31, 2014
Corbin brings 23 years of experience   Read More »
Kristin Brooks
January 31, 2014
Melingo brings 30 years of industry experience  Read More »
Gil Roth
January 30, 2014
Oncology drugs fuel growth  Read More »
Kristin Brooks
January 30, 2014
To provide imaging services for multi-site oncology trial  Read More »
Kristin Brooks
January 30, 2014
To commercialize MS, hemophilia assets in the region  Read More »
Kristin Brooks
January 30, 2014
Large-scale license includes the use of 250 in vitro disease models  Read More »
Kristin Brooks
January 30, 2014
Xenetic receives $10M equity investment, eligible for $100M in milestones   Read More »
Kristin Brooks
January 30, 2014
Aims to increase accessibility and preserve client data  Read More »
Kristin Brooks
January 30, 2014
To supply insulin pen components for Sanofi diabetes treatment  Read More »
Gil Roth
January 30, 2014
Service revenues rise across the board, with 30% bump for Perceptive Informatics unit  Read More »
Kristin Brooks
January 30, 2014
$5 mil expansion provides lab space, instrumentation to support growth  Read More »
Gil Roth
January 30, 2014
Soliris sales continue to climb  Read More »
Gil Roth
January 30, 2014
Cymbalta expiration begins to weigh down sales  Read More »

Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On